A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 8112557)

Published in Gen Hosp Psychiatry on November 01, 1993

Authors

C H Silberstein1, M A O'Dowd, P Chartock, E E Schoenbaum, G Friedland, D Hartel, F P McKegney

Author Affiliations

1: Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467.

Articles by these authors

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43

Public health implications of antiretroviral therapy and HIV drug resistance. JAMA (1998) 4.72

Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72

Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer (1980) 4.31

Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43

Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med (1981) 3.25

An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med (1986) 3.12

Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care (2005) 3.06

Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med (1989) 2.73

Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36

Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis (2000) 2.25

High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19

Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98

Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92

Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75

Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health (1989) 1.70

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68

Protocol management of dysuria, urinary frequency, and vaginal discharge. Ann Intern Med (1974) 1.64

Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63

A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54

Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci (1991) 1.50

Infusion-related phlebitis--is the in-line filter the solution? N Engl J Med (1985) 1.48

Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48

Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2011) 1.47

Adherence, compliance, and HAART. AIDS Clin Care (1997) 1.40

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40

Computer linkage of psychiatric emergency rooms. Hosp Community Psychiatry (1992) 1.39

A fallacy of subspecialization in psychiatry. Consultation-liaison is a supraspecialty. Psychosomatics (1991) 1.38

Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis (1997) 1.36

A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care (2008) 1.35

Injection drug use and human immunodeficiency virus infection. Clin Infect Dis (1995) 1.31

The community health visitor program: a student-organized experiment. J Med Educ (1969) 1.29

Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care. Int J Tuberc Lung Dis (2008) 1.28

End-of-life decisions in HIV-positive patients: the role of spiritual beliefs. AIDS (1998) 1.25

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1998) 1.22

Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18

Management strategies for urinary and vaginal infections. Arch Intern Med (1978) 1.16

Organic factors and psychological adjustment in advanced cancer patients. Psychosom Med (1974) 1.15

Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.14

Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection. Clin Infect Dis (1996) 1.09

Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis (1991) 1.06

Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04

Suicidal behavior among inner-city Hispanic adolescent females. Gen Hosp Psychiatry (1991) 1.03

The dysuria-pyuria syndrome. N Engl J Med (1980) 1.02

A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02

Correlates of voluntary human immunodeficiency virus antibody testing reported by postpartum women. J Am Med Womens Assoc (1997) 1.01

Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99

Religion in patients with advanced cancer. Med Pediatr Oncol (1981) 0.99

Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int J Tuberc Lung Dis (2010) 0.98

Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS (1997) 0.96

Hypertension control among employed persons in New York City: 1973-75. Milbank Mem Fund Q Health Soc (1976) 0.95

Antibody to the human immunodeficiency virus in women seeking abortion in New York City. Ann Intern Med (1987) 0.94

Behavioral risks for HIV infection associated with HIV-testing decisions. AIDS Educ Prev (1996) 0.94

Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict (2001) 0.93

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS (1999) 0.93

Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City. Am J Perinatol (2001) 0.92

Antiretroviral prophylaxis of health care workers at two urban medical centers. J Occup Environ Med (2000) 0.92

In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.91

Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy. Infect Dis Clin North Am (2000) 0.91

The dialysis exercise: a learning simulation for medical students. Med Educ (1981) 0.91

Strategies for diagnosing vaginitis. J Fam Pract (1979) 0.90

Interaction of methadone with didanosine and stavudine. J Acquir Immune Defic Syndr (2000) 0.90

Body image in older men with or at-risk for HIV infection. AIDS Care (2007) 0.90

Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun (1999) 0.90

Body image in middle-aged HIV-infected and uninfected women. AIDS Care (2006) 0.89

A psychosomatic comparison of patients with ulcerative colitis and Crohn's disease. Psychosom Med (1970) 0.88

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med (2006) 0.88

Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol (1994) 0.87

Demographic characteristics, drug use, and sexual behavior of i.v. drug user with AIDS in Bronx, New York. Public Health Rep (1991) 0.87

Prediction and management of pain in patients with advanced cancer. Gen Hosp Psychiatry (1981) 0.87

Incidence of suicidality in AIDS and HIV-positive patients attending a psychiatry outpatient program. Psychosomatics (1993) 0.87

Psychobiologic factors and individual survival on chronic renal hemodialysis. A two year follow-up. I. Psychosom Med (1973) 0.86

A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use. Clin Infect Dis (2001) 0.86

Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev (1995) 0.86

The incidence and characteristics of patients with conversion reactions. I. A general hospital consultation service sample. Am J Psychiatry (1967) 0.85

The intensive care syndrome. The definition, treatment and prevention of a new "disease of medical progress". Conn Med (1966) 0.85

Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.85

Pyrogen reactions associated with the infusion of normal serum albumin (human). Transfusion (1978) 0.84

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214. J Infect Dis (2000) 0.84

Hospice care of the intravenous drug user AIDS patient in a skilled nurse facility. J Acquir Immune Defic Syndr (1988) 0.84

Evaluative research in consultation-liaison psychiatry. Review of the literature: 1970-1981. Gen Hosp Psychiatry (1982) 0.84

A mental health training program in nursing homes. Gerontologist (1988) 0.83

A simplified method for assessing PHA induced stimulation of rat peripheral blood lymphocytes. J Immunol Methods (1982) 0.83

Three oral formulations of methadone. A clinical and pharmacodynamic comparison. J Subst Abuse Treat (1999) 0.82

Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia. J Infect Dis (1996) 0.82

Febrile inpatients: house officers' use of blood cultures. J Gen Intern Med (1987) 0.82

Infectiousness of laryngeal tuberculosis. Am Rev Respir Dis (1976) 0.82